[1] Pellegriti G, Frasca F, Regalbuto C, et al.Worldwide increasing incidence of thyroid cancer: update on epidemio-logy and risk factors[J]. J Cancer Epidemiol,2013,2013:965212. [2] 艾志龙. 桥本甲状腺炎的外科诊治[J]. 外科理论与实践,2014,19(3):205-207. [3] Liang J, Zeng W, Fang F, et al.Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1 392 patients[J]. Acta Otorhinolaryngol Ital,2017,37(5):393-400. [4] 陈曦. 从外科角度看甲状腺炎[J]. 外科理论与实践, 2012,17(1):4-6. [5] Kurukahvecioglu O, Taneri F, Yuksel O, et al.Total thyroidectomy for the treatment of Hashimoto′s thyroiditis coexisting with papillary thyroid carcinoma[J]. Adv Ther,2007,24(3):510-516. [6] Cordioli MI, Cury AN, Nascimento AO, et al.Study of the histological profile of papillary thyroid carcinomas associated with Hashimoto's thyroiditis[J]. Arq Bras Endocrinol Metabol,2013,57(6):445-449. [7] McLeod DS, Watters KF, Carpenter AD, et al. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis[J]. J Clin Endocrinol Metab,2012,97(8):2682-2692. [8] Park YM, Kim JR, Oh KH, et al. Comparison of functional outcomes after total thyroidectomy and completion thyroidectomy: Hypoparathyroidism and postoperative complications[J]. Auris Nasus Larynx,2018-04-07. pii: S0385-8146(17)30846-5.doi:10.1016/j.anl.2018.03.009. [9] Anand A, Singh KR, Kushwaha JK, et al.Papillary thyroid cancer and Hashimoto's thyroiditis: an association less understood[J]. Indian J Surg Oncol,2014,5(3):199-204. [10] Jeong JS, Kim HK, Lee CR, et al.Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome[J]. J Korean Med Sci,2012,27(8):883-889. [11] Kim SS, Lee BJ, Lee JC, et al.Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis[J]. Head Neck,2011, 33(9):1272-1277. [12] Kimura H, Yamashita S, Namba H, et al.Interleukin-1 inhibits human thyroid carcinoma cell growth[J]. J Clin Endocrinol Metab,1992,75(2):596-602. [13] Kim SK, Song KH, Lim SD, et al.Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis[J]. Thyroid,2009,19(2):137-141. |